T. Rowe Price Associates’s Tango Therapeutics TNGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $197K | Buy |
38,401
+16,149
| +73% | +$82.8K | ﹤0.01% | 2718 |
|
|
2025
Q1 | $31K | Buy |
22,252
+1,254
| +6% | +$1.75K | ﹤0.01% | 2980 |
|
|
2024
Q4 | $65K | Buy |
20,998
+4,813
| +30% | +$14.9K | ﹤0.01% | 2890 |
|
|
2024
Q3 | $125K | Buy |
16,185
+951
| +6% | +$7.35K | ﹤0.01% | 2777 |
|
|
2024
Q2 | $131K | Buy |
15,234
+2,463
| +19% | +$21.2K | ﹤0.01% | 2704 |
|
|
2024
Q1 | $102K | Buy |
12,771
+1,426
| +13% | +$11.4K | ﹤0.01% | 2781 |
|
|
2023
Q4 | $113K | Buy |
11,345
+1,129
| +11% | +$11.2K | ﹤0.01% | 2693 |
|
|
2023
Q3 | $116K | Buy |
+10,216
| New | +$116K | ﹤0.01% | 2628 |
|